TELUS Corp. (T.TO, TU) was downgraded to hold from buy at Desjardins on Wednesday.
Analyst Jerome Dubreuil lowered the price target to C$13.50 from C$19 a share for the telecom company.
"We acknowledge that we are not early to this trade" Dubreuil said in a note to clients. "However, the scale of the guidance reset means T's valuation premium to peers has barely moved despite the 11% share price decline on July 31."
TELUS (T.TO) was downgraded to Underperform from Buy at Bank of America Securities on Tuesday.The price objective was cut to C$13 from C$22 on a "materially lower" free cash flow outlook for 2028, the firm said in a note."Our bull thesis of strong FCF growth and execution on monetizations has not played out, resulting in our changed view," BofA Securities said.Price: $13.09, Change: $-0.29, Percent Change: -2.17%
Inspire Medical Systems (INSP) has an average rating of hold and mean price target of $57.21, according to analysts polled by FactSet.
Vishay Intertechnology (VSH) has an average rating of overweight and mean price target of $38.25, according to analysts polled by FactSet.